India Drug Delivery Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

The market is segmented by Mode of Administration (Nasal, Oral, Ocular, Implantable, Injectable, Transdermal, Topical and Other Modes of Administration), and End User

Market Snapshot

Study Period:


Base Year:


80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

India has the second-largest population in the world according to OECD data. With the increasing population, demand for better healthcare facilities has also increased. Newer and efficient ways of drug delivery devices have been positively affected by this demand and hence this market is flourishing in India.

It is not just the growing population, but also the increasing prevalence of chronic diseases that have caused a burden on the Indian population. This has proven to be the major factor for the ease in demand for drug delivery devices. Other factors like technological advancements in the field of drug delivery and demand for controlled release drugs have also affected this market positively.

However, increase in the risk of infections and side effects from these devices and stringent regulatory guidelines for the approval of drug delivery devices have been restraining the growth of this market.

Scope of the Report

Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. These devices are used as part of medical treatments.

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Oral mode of administration is expected to dominate in the forecast period

Oral drug delivery devices are traditional and most trusted routes of drug delivery, with successful systemic and local effects. The benefit of the availability of the maximum active surface for drug delivery, in the oral route of administration, makes it the most convenient and most preferred route of drug administration.

With the advent of novel drug delivery systems, oral controlled drug delivery systems have gained pace, in recent times. Oral drug delivery systems have been enhanced by the development of advanced time-controlled drug delivery system, with the help of modern mathematical models, sophisticated instrumentation, and computational power, in order to revolutionize the entire process of formulation. In the field of oral controlled release drug delivery system, in-situ forming, oral controlled release formulation is an innovative technology that is being widely adopted in India.

Hence, the aforementioned factors are expected to propel the overall growth of the segment, over the forecast period.

To understand key trends, Download Sample Report

Competitive Landscape

The market studied in India is moderately competitive and comprises of the international as well as local players. India has been attracting global pharmaceutical players. These companies have benefitted themselves from the Indian market due to increasing demands. This only persuaded many other global companies to enter the Indian market. Many domestic pharmaceutical manufacturers have also established themselves as key players.

Table Of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Prevalence of Chronic Diseases

      2. 4.2.2 Requirement of Controlled Drug Release

      3. 4.2.3 Technological Advances in Drug Delivery

    3. 4.3 Market Restraints

      1. 4.3.1 Risk of Infection during the Usage

      2. 4.3.2 Stringent Regulatory Guidelines

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Mode of Administration

      1. 5.1.1 Nasal

      2. 5.1.2 Oral

      3. 5.1.3 Ocular

      4. 5.1.4 Implantable

      5. 5.1.5 Injectable

      6. 5.1.6 Transdermal

      7. 5.1.7 Topical

      8. 5.1.8 Other Modes of Administration

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Ambulatory Centers

      3. 5.2.3 Other End Users


    1. 6.1 Company Profiles

      1. 6.1.1 3M Company

      2. 6.1.2 Bayer AG

      3. 6.1.3 F. Hoffmann-La Roche AG

      4. 6.1.4 GlaxoSmithKline PLC

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 Merck & Co

      7. 6.1.7 Novartis AG

      8. 6.1.8 Pfizer Inc

      9. 6.1.9 Sanofi

      10. 6.1.10 Sun Pharmaceutical Industries Ltd.

  7. *List Not Exhaustive

** Subject to Availability

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

Related Reports